Vantage logo

Axsome rides the bull case

Axsome is heading to regulators in the wake of a second successful depression study, and investors are predicting huge success. What could possibly go wrong?

Vantage logo

Round two for Axsome

Fresh from a mid-stage success in depression Axsome offers an unusual way to trade its upcoming phase III result.